Dana-Farber Cancer Institute: all 833 studies

Page 4 of 9. Open to participants first (121), then studies with results posted, then the rest; newest registration first within each.

• Early Changes In Multiparametric MRI In Prostate CancerCompletedNCT01959542Not applicableResults posted
• GSK1120212+GSK2141795 for Cervical CancerTerminatedNCT01958112Phase 2Results posted
• Study of Enzalutamide in Patients With Castration-resistant Prostate CancerCompletedNCT01942837Phase 2Results posted
• Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast CancerTerminatedNCT01912963Phase 2Results posted
• A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate CancerCompletedNCT01858688Not applicableResults posted
• T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)CompletedNCT01853748Phase 2Results posted
• Sunitinib in Never-Smokers With Lung AdenocarcinomaCompletedNCT01829217Phase 2Results posted
• Eribulin in HER2 Negative Metastatic BrCaCompletedNCT01827787Phase 2Results posted
• Melatonin Versus Placebo in Breast CancerCompletedNCT01805089Early Phase 1Results posted
• Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)TerminatedNCT01799135Not applicableResults posted
• Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCaCompletedNCT01796197Phase 2Results posted
• BKM120 For Triple Negative Breast CancerCompletedNCT01790932Phase 2Results posted
• A Phase II Trial of Regadenoson in Sickle Cell AnemiaCompletedNCT01788631Phase 2Results posted
• Ziv-Aflibercept for Advanced Progressive Carcinoid TumorsCompletedNCT01782443Phase 2Results posted
• GVAX vs. Placebo for MDS/AML After Allo HSCTTerminatedNCT01773395Phase 2Results posted
• Ponatinib for Squamous Cell Lung and Head and Neck CancersTerminatedNCT01761747Phase 2/3Results posted
• Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell TransplantCompletedNCT01754389Phase 2Results posted
• FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric CancerCompletedNCT01747551Phase 2Results posted
• CHOEP + High Dose Therapy + Auto SCT for T-Cell LymphomaTerminatedNCT01746173Phase 2Results posted
• Cabozantinib for Metastatic Triple Negative BrCaCompletedNCT01738438Phase 2Results posted
• Cosmetic Result/Toxicity in Post-Mastectomy Immediate Reconstruction Expander+RTCompletedNCT01664091Not applicableResults posted
• Ibrutinib (PCI-32765) in Waldenstrom's MacroglobulinemiaCompletedNCT01614821Phase 2Results posted
• SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic LymphomaActive, not recruitingNCT01574274Phase 2Results posted
• Ruxolitinib in Patients With Breast CancerTerminatedNCT01562873Phase 2Results posted
• Fulvestrant With or Without Ganetespib in HR+ Breast CancerCompletedNCT01560416Phase 2Results posted
• STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV MelanomaTerminatedNCT01551693Phase 2Results posted
• Study of Vitamin D in Untreated Metastatic Colorectal CancerCompletedNCT01516216Phase 2Results posted
• HKI-272 for HER2-Positive Breast Cancer and Brain MetastasesCompletedNCT01494662Phase 2Results posted
• Dasatinib in Advanced Squamous Cell Lung CancerTerminatedNCT01491633Phase 2Results posted
• Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple MyelomaTerminatedNCT01484314Phase 2Results posted
• Carfilzomib, Rituximab and Dexamethasone in Waldenstrom's MacroglobulinemiaCompletedNCT01470196Phase 2Results posted
• Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid TumorsCompletedNCT01466036Phase 2Results posted
• Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLLTerminatedNCT01465334Phase 2Results posted
• Image-Guided Gynecologic BrachytherapyCompletedNCT01399658Phase 2Results posted
• Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-DiseaseActive, not recruitingNCT01366092Phase 2Results posted
• Exercise and Metformin in Colorectal and Breast Cancer SurvivorsCompletedNCT01340300Phase 2Results posted
• Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related DonorsCompletedNCT01323920Phase 2Results posted
• Amgen 386 for Recurrent GlioblastomaCompletedNCT01290263Phase 1/2Results posted
• Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic CancerCompletedNCT01273805Phase 2Results posted
• Pazopanib in Patients With Relapsed or Refractory Small Cell Lung CancerCompletedNCT01253369Phase 2Results posted
• FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal CancerCompletedNCT01243619Not applicableResults posted
• Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host DiseaseTerminatedNCT01226420Phase 2Results posted
• Stereotactic Boost for Locally Advanced Non-Small Cell Lung CancerTerminatedNCT01222572Phase 1/2Results posted
• Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma StudyTerminatedNCT01221753Phase 2Results posted
• STA-9090(Ganetespib) in Metastatic Ocular MelanomaCompletedNCT01200238Phase 2Results posted
• CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric CancerCompletedNCT01191697Phase 2Results posted
• Trastuzumab and Vinorelbine in Advanced Breast CancerTerminatedNCT01185509Phase 2Results posted
• Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial CancerCompletedNCT01184326Phase 1Results posted
• Methylphenidate for Cancer-Related FatigueTerminatedNCT01164956Phase 1Results posted
• Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's MacroglobulinemiaTerminatedNCT01125293Phase 1/2Results posted
• Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell DiseaseCompletedNCT01085201Phase 1Results posted
• Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT01066663Phase 1/2Results posted
• RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal CancerCompletedNCT01058655Phase 1/2Results posted
• AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine TumorsCompletedNCT01024387Phase 2Results posted
• Carboplatin and Bevacizumab for Progressive Breast Cancer Brain MetastasesCompletedNCT01004172Phase 2Results posted
• Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell DiseaseTerminatedNCT01000155Phase 2Results posted
• Everolimus (RAD001) in Primary Therapy of Waldenstrom's MacroglobulinemiaCompletedNCT00976248Phase 2Results posted
• Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate CancerTerminatedNCT00953576Phase 1/2Results posted
• RAD001 for Patients With Radioiodine Refractory Thyroid CancerCompletedNCT00936858Phase 2Results posted
• LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's MacroglobulinemiaCompletedNCT00936611Phase 2Results posted
• Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With LymphomaCompletedNCT00928018Phase 3Results posted
• Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast CancerTerminatedNCT00925652Phase 2Results posted
• Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerCompletedNCT00911820Phase 2Results posted
• Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian CancerTerminatedNCT00910000Phase 1/2Results posted
• Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple MyelomaCompletedNCT00903968Phase 1/2Results posted
• Extended Endocrine Therapy for Premenopausal Women With Breast CancerCompletedNCT00903162Phase 2Results posted
• Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic CancerTerminatedNCT00889187Phase 1/2Results posted
• Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast CancerCompletedNCT00880464Phase 1Results posted
• Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCCCompletedNCT00880334Phase 2Results posted
• Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian MalignanciesCompletedNCT00856180Phase 2Results posted
• Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine LeiomyosarcomaCompletedNCT00856050Phase 2Results posted
• A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal CarcinomaCompletedNCT00834093Phase 2Results posted
• Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host DiseaseCompletedNCT00815919Phase 2Results posted
• Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial CarcinomaCompletedNCT00808639Phase 2Results posted
• A Pilot Study of Acupuncture Treatment for DysphagiaCompletedNCT00797732Not applicableResults posted
• Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged MelanomaCompletedNCT00788775Phase 2Results posted
• Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade GliomasCompletedNCT00782626Phase 2Results posted
• Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local TherapyCompletedNCT00776594Phase 2Results posted
• Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal CarcinomaCompletedNCT00768144Phase 2Results posted
• Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's LymphomaCompletedNCT00684411Phase 2Results posted
• Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate CancerCompletedNCT00658697Phase 2Results posted
• Deferoxamine for Iron Overload Before Allogeneic Stem Cell TransplantationTerminatedNCT00658411Not applicableResults posted
• RAD001 and Bicalutamide for Androgen Independent Prostate CancerCompletedNCT00630344Phase 2Results posted
• Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerTerminatedNCT00611858Phase 2Results posted
• Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's DiseaseCompletedNCT00601146Not applicableResults posted
• Vitamin D for ChemopreventionCompletedNCT00585637Phase 1Results posted
• SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous MelanomaCompletedNCT00577382Phase 2Results posted
• RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine TumorsCompletedNCT00576680Phase 1/2Results posted
• Simvastatin in Waldenstrom's MacroglobulinemiaTerminatedNCT00575965Phase 2Results posted
• Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and NeckTerminatedNCT00570674Phase 1/2Results posted
• Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell TransplantationTerminatedNCT00548717Phase 2Results posted
• Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological CancersCompletedNCT00545792Phase 2Results posted
• Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast CancerCompletedNCT00542451Phase 2Results posted
• Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host DiseaseCompletedNCT00529035Phase 1Results posted
• Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian TumorsCompletedNCT00520013Phase 2Results posted
• Campath in Chronic GVHDCompletedNCT00495755Phase 1Results posted
• Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple MyelomaCompletedNCT00483262Phase 1/2Results posted
• Erlotinib in Women With Squamous Cell Carcinoma of the VulvarCompletedNCT00476476Phase 2Results posted
• ALL Adult Consortium Trial: Adult ALL TrialCompletedNCT00476190Phase 2Results posted
• Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the UterusCompletedNCT00476086Phase 2Results posted

← Dana-Farber Cancer Institute overview and focus areas